Technetium-MIBI as a glioma imaging agent for the assessment of multi- drug resistance

Neurosurgery

Volumn 40, Issue 6, 1997, Pages 1323-1334

  Andrews, David W ^a   Das, Rita ^a   Kim, Sung ^a   Zhang, James ^a   Curtis, Mark ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

glioma; multi drug resistance; sesta MIBI; SPECT imaging; thallium

Indexed keywords

GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOMA; HEADACHE; HUMAN; HUMAN TISSUE; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBECTOMY; VERTIGO;

EID: 0030940293     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199706000-00047     Document Type: Article

References (31)

1. m-sestamibi. Nucl Med Comm 16:258-26, 1995
2. Baillet G, Albuquerque, Chen Q, Poisson M, Delattre JY: Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eu Jour of Nuc Med 21-10:1061-1066, 1994
3. Baldini N, Scotlandi, K, Barbanti-Bròdano G, Cristina-Manara M, Maurici D, Bacci G, Bertoni F, Picci, P, Sottili S, Campanacci M, Serra, M: Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Eng J Med. 1995; 333:21: 1380-1385.
4. Bogler O, Huang HJ, Kleihues P, Cavenee WK: The p53 gene and its role in human brain tumors Glia 15 (3):308-27, 1995
5. Cairncross D, Macdonald D, Ludwin S. Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Steward D, Schold C: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12(10):2013-21, 1994
6. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BG, Taylor CW, Miller TP, Salmon SE: Drug-resistance in multiple myeloma and non Hodgkin's lymphoma: detection of P-glcoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7:L415-24, 1989
7. Das R, Reddy P, Chatterjee D, Andrews, DW: Identification of a novel Bcl-2 related gene, BRAG-1, in human glioma Oncogene 12:947-951, 1996
8. Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137-171
9. Feun LG, Savaraj N, Landy HJ: Drug resistance in brain tumors. J Neuro-Oncol. 1994; 20: 165-176.
10. Gotterman M. and Pastan I: The multidrug transporter, a double-edged sword. J.Biol Chem 263:12163-12166, 1988
11. Kim SM, Zhang JJ, Andrews DW: Evaluation of supratentorial gliomas with Tc-99m-MIBI brain SPECT: comparison with T1-201 SPECT. Radiology 201(P): 339, 1996
12. Kimmel DW, Shapiro JR, Shapiro WR: In vitro drug sensitivity testing in human gliomas. J Neurosurgery 66:161-171, 1987
13. Kyritsis AP, Zu R, Bondy ML, Levin VA, Bruner JH: Correlation of p53 immunoreactivity and sequencing in patients with glioma Molecular Carcinogenesis 15(1):1-4, 1996
14. Lorbergoym M, Baram J, Feibel M, Herchergs A, Lieberman L: A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden. Int J Rad Onc Biol Phys 32:249-254 (1995)
15. Matsumoto T, Tani E, Kaba K, Kochi N, Shindo H, Yamamoto Y, Sakamoto H and Furuyama J: Amplication and expression of a multidrug resistance gene in human glioma cell lines. J Neurosurgery 72:96-101, 1990
16. Matsumoto T, Tani E, Kaba K, Shindo H, Miyaji K: Expression of p-glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurgery 74:460-466, 1991
17. Moretti JL, Caglar M, Duran-Cordobes M, Morere JF: Can nuclear medicine predict response to chemotherapy? Eur J Nucl Med. 1995; 22: 97-100.
18. Mousseau M, Chauvin C, Nissou MF, Chaffanet M, Plantaz D, Pasquier B, Schaerer R, Benabid A: A study of the expression of four chemoresistance-related genes in human pimary and metastatic brain tumors. Eur J Cancer, 29A-5 753-759, 1993
19. Noonan KE, Beck C, HoLzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB: Quantitative analysis of MDR-1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci. USA 1990; 87: 7160-7164.
20. O' Tuama LA, Packard AB, Trever ST: SPECT imaging of pediatric brain tumors with hexakis (methoxyisobutylisnonitrile) technetium. J. Nucl Med 31:20040-2041 1990
21. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer R, Croop J: Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 977-984.
22. Rao VV, Chui ML, Kronauge JF, Piwnica-Worms D: Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99-sestamibi. J Nucl Med 1994; 35:3: 510-515.
23. Roninson JB, (ed.) Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, New York:: Plenum Publishing Corp. 1991
24. Salmon SE, Dalton WS, Grogan TM, Plezia P, Lehnert M, Roe DJ, Miller TP: Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer. Blood 78:44-50, 1991
25. Sonneveld P, Durie BGM, Lokhorst HM, Marie JP, Solbu G, Suciu S, Zittoun R, Lowenberg B, Nooter K: Modulation of multidrug resistant multiple myeloma by cyclosporin. Lancet 340:255-9, 1992
26. Sonneveld P, Schoester M, de Leeuw K: Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells. J. Clin Oncol 12:1584-91, 1994
27. Twentyman PR: Cyclosporins as drug resistance modifiers. Biochem Pharmacol 43:109-17, 1992
28. Yahanda AM, Bruner JM, Donehower LA, Morrison RS: Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas Molec & Cel Bio 15(8):4249-59, 1995
29. Yusa K, Tsuruo T: Reversal mechanism of multidrug resistance by verapmil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res 49:5002-6, 1989
30. Zhang JJ, Kim SM, Andrews DW: Comparative assessment of four different thallium tumor uptakes indices in the evaluation of the recurrent brain tumor. J Nuc Med 37(5):157P, 1996
31. Zhang JJ, Kim SM, Andrews DW: Tumor concentration index compared with maximum tumor index in the evaluation of recurrent brain tumor: correlation with clinical outcome. Radiology 201 (P):331, 1996